NICOLOTTI, ORAZIO
NICOLOTTI, ORAZIO
DIPARTIMENTO DI FARMACIA-SCIENZE DEL FARMACO
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships
2008-01-01 Stefanachi, Angela; Nicolotti, Orazio; Leonetti, Francesco; Cellamare, Saverio; Campagna, Francesco; Loza, Mi; Brea, Jm; Mazza, F; Gavuzzo, E; Carotti, Angelo
1,3-Dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships
2009-01-01 Fernandez, F; Caamano, O; Nieto, Mi; Lopez, C; Garcia Mera, X; Stefanachi, Angela; Nicolotti, Orazio; Loza, Mi; Brea, J; Esteve, C; Segarra, V; Vidal, B; Carotti, Angelo
17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer
2021-01-01 Gargano, E. M.; Mohamed, A.; Abdelsamie, A. S.; Mangiatordi, G. F.; Drzewiecka, H.; Jagodzinski, P. P.; Mazzini, A.; Van Koppen, C. J.; Laschke, M. W.; Nicolotti, O.; Carotti, A.; Marchais-Oberwinkler, S.; Hartmann, R. W.; Frotscher, M.
4-(Alkylamino)methyl-substituted coumarins as potent and selective AChE and MAO-B dual inhibitors with a therapeutic potential in neurodegenerative disorders
2013-01-01 Pisani, L.; Catto, M.; Stefanachi, A.; Leonetti, F.; Campagna, F.; Nicolotti, O.; Soto-Otero, R.; Carotti, A.
6-Substituted-(E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides as novel, potent and selective MAO inhibitors
2011-01-01 Barletta, M.; Pisani, Leonardo; Catto, Marco; Nicolotti, Orazio; Soto Otero, R.; Carotti, Angelo
8-Substituted- 9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B
2004-01-01 Carotti, Angelo; Stefanachi, Angela; Ravina, E; Sotelo, E; Loza, Mi; Cadavid, Mi; Centeno, Nb; Nicolotti, Orazio
9-Deazaxanthines as selective A2B AR ligands: Design, Synthesis and SAFIR studies
2004-01-01 Carotti, A; CADAVID M., I; CENTENO N., B; Esteve, C; Fontaine, F; GUTIÉRREZ DE TERÁN, H; LOZA M., I; Martinez, A; Nicolotti, Orazio; Nieto, R; Pastor, M; Raviña, E; Sanz, F; Segarra, V; Sotelo, E; Stefanachi, Angela
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor.
2010-01-01 Nicolotti, Orazio; Giangreco, I; Pisani, Leonardo; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Cellamare, Saverio; Carotti, A.
A multi-objective approach to deriving QSAR models
2003-01-01 Nicolotti, Orazio; Gillet, Vj; Fleming, P; Green, D.
A Multi-Objective Optimization Algorithm for Molecular Design
2009-01-01 Giangreco, I; Nicolotti, Orazio; Miscioscia T., F; Convertino, M; Mangiatordi G., F; Siragusa, L; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Carotti, A.
A multiobjective approach to deriving QSAR models
2004-01-01 Nicolotti, Orazio; Gillet, Vj; Fleming, P; Green, D.
A multitarget approach in cancer research
2009-01-01 Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A.
A multitarget approach in cancer research. Joint Meeting on Medicinal Chemistry
2009-01-01 Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A.
A new approach to combine ligand- and structure-based drug design.
2008-01-01 Nicolotti, Orazio; Miscioscia, Tf; Carotti, A; Leonetti, Francesco; Giangreco, I; Carotti, A.
A novel function for non-deterministic scouting of optimal QSAR models out of a highly-structured physicochemical space.
2006-01-01 Nicolotti, Orazio; Miscioscia T., F; Leonetti, Francesco; Carotti, A.
Accelerating drug discovery by early protein drug target prediction based on a multi-fingerprint similarity search †
2019-01-01 Montaruli, M.; Alberga, D.; Ciriaco, F.; Trisciuzzi, D.; Tondo, A. R.; Mangiatordi, G. F.; Nicolotti, O.
Activation of Rho Family GTPases by Small Molecules
2018-01-01 Palsuledesai, Charuta C.; Surviladze, Zurab; Waller, Anna; Miscioscia, T. Fabiola; Guo, Yuna; Wu, Yang; Strouse, Jake; Romero, Elsa; Salas, Virginia M.; Curpan, Ramona; Young, Susan; Carter, Mark; Foutz, Terry; Galochkina, Zhanna; Ames, Harold; Haynes, Mark K.; Edwards, Bruce S.; Nicolotti, Orazio; Luo, Li; Ursu, Oleg; Bologa, Cristian G.; Oprea, Tudor I.; Wandinger-Ness, Angela; Sklar, Larry A.
Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?
2014-01-01 Cruz Monteagudo, M; Medina Franco, Jl; Pérez Castillo, Y; Nicolotti, Orazio; Cordeiro, Mnds; Borges, F.
Aldoxime- and hydroxy-functionalized chalcones as highly potent and selective monoamine oxidase-B inhibitors
2022-01-01 Oh, J. M.; Rangarajan, T. M.; Chaudhary, R.; Gambacorta, N.; Nicolotti, O.; Kumar, S.; Mathew, B.; Kim, H.
Alloxan Derivatives as Inhibitors of Matrix Metalloproteinase-2: Theoretical Calculations and Experimental Results
2010-01-01 Lattanzi, Gianluca; Ilenia, Giangreco; Nicolotti, Orazio; Catto, Marco; Angelo, Carotti
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships | 1-gen-2008 | Stefanachi, Angela; Nicolotti, Orazio; Leonetti, Francesco; Cellamare, Saverio; Campagna, Francesco; Loza, Mi; Brea, Jm; Mazza, F; Gavuzzo, E; Carotti, Angelo | |
1,3-Dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships | 1-gen-2009 | Fernandez, F; Caamano, O; Nieto, Mi; Lopez, C; Garcia Mera, X; Stefanachi, Angela; Nicolotti, Orazio; Loza, Mi; Brea, J; Esteve, C; Segarra, V; Vidal, B; Carotti, Angelo | |
17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer | 1-gen-2021 | Gargano, E. M.; Mohamed, A.; Abdelsamie, A. S.; Mangiatordi, G. F.; Drzewiecka, H.; Jagodzinski, P. P.; Mazzini, A.; Van Koppen, C. J.; Laschke, M. W.; Nicolotti, O.; Carotti, A.; Marchais-Oberwinkler, S.; Hartmann, R. W.; Frotscher, M. | |
4-(Alkylamino)methyl-substituted coumarins as potent and selective AChE and MAO-B dual inhibitors with a therapeutic potential in neurodegenerative disorders | 1-gen-2013 | Pisani, L.; Catto, M.; Stefanachi, A.; Leonetti, F.; Campagna, F.; Nicolotti, O.; Soto-Otero, R.; Carotti, A. | |
6-Substituted-(E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides as novel, potent and selective MAO inhibitors | 1-gen-2011 | Barletta, M.; Pisani, Leonardo; Catto, Marco; Nicolotti, Orazio; Soto Otero, R.; Carotti, Angelo | |
8-Substituted- 9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B | 1-gen-2004 | Carotti, Angelo; Stefanachi, Angela; Ravina, E; Sotelo, E; Loza, Mi; Cadavid, Mi; Centeno, Nb; Nicolotti, Orazio | |
9-Deazaxanthines as selective A2B AR ligands: Design, Synthesis and SAFIR studies | 1-gen-2004 | Carotti, A; CADAVID M., I; CENTENO N., B; Esteve, C; Fontaine, F; GUTIÉRREZ DE TERÁN, H; LOZA M., I; Martinez, A; Nicolotti, Orazio; Nieto, R; Pastor, M; Raviña, E; Sanz, F; Segarra, V; Sotelo, E; Stefanachi, Angela | |
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor. | 1-gen-2010 | Nicolotti, Orazio; Giangreco, I; Pisani, Leonardo; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Cellamare, Saverio; Carotti, A. | |
A multi-objective approach to deriving QSAR models | 1-gen-2003 | Nicolotti, Orazio; Gillet, Vj; Fleming, P; Green, D. | |
A Multi-Objective Optimization Algorithm for Molecular Design | 1-gen-2009 | Giangreco, I; Nicolotti, Orazio; Miscioscia T., F; Convertino, M; Mangiatordi G., F; Siragusa, L; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Carotti, A. | |
A multiobjective approach to deriving QSAR models | 1-gen-2004 | Nicolotti, Orazio; Gillet, Vj; Fleming, P; Green, D. | |
A multitarget approach in cancer research | 1-gen-2009 | Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A. | |
A multitarget approach in cancer research. Joint Meeting on Medicinal Chemistry | 1-gen-2009 | Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A. | |
A new approach to combine ligand- and structure-based drug design. | 1-gen-2008 | Nicolotti, Orazio; Miscioscia, Tf; Carotti, A; Leonetti, Francesco; Giangreco, I; Carotti, A. | |
A novel function for non-deterministic scouting of optimal QSAR models out of a highly-structured physicochemical space. | 1-gen-2006 | Nicolotti, Orazio; Miscioscia T., F; Leonetti, Francesco; Carotti, A. | |
Accelerating drug discovery by early protein drug target prediction based on a multi-fingerprint similarity search † | 1-gen-2019 | Montaruli, M.; Alberga, D.; Ciriaco, F.; Trisciuzzi, D.; Tondo, A. R.; Mangiatordi, G. F.; Nicolotti, O. | |
Activation of Rho Family GTPases by Small Molecules | 1-gen-2018 | Palsuledesai, Charuta C.; Surviladze, Zurab; Waller, Anna; Miscioscia, T. Fabiola; Guo, Yuna; Wu, Yang; Strouse, Jake; Romero, Elsa; Salas, Virginia M.; Curpan, Ramona; Young, Susan; Carter, Mark; Foutz, Terry; Galochkina, Zhanna; Ames, Harold; Haynes, Mark K.; Edwards, Bruce S.; Nicolotti, Orazio; Luo, Li; Ursu, Oleg; Bologa, Cristian G.; Oprea, Tudor I.; Wandinger-Ness, Angela; Sklar, Larry A. | |
Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde? | 1-gen-2014 | Cruz Monteagudo, M; Medina Franco, Jl; Pérez Castillo, Y; Nicolotti, Orazio; Cordeiro, Mnds; Borges, F. | |
Aldoxime- and hydroxy-functionalized chalcones as highly potent and selective monoamine oxidase-B inhibitors | 1-gen-2022 | Oh, J. M.; Rangarajan, T. M.; Chaudhary, R.; Gambacorta, N.; Nicolotti, O.; Kumar, S.; Mathew, B.; Kim, H. | |
Alloxan Derivatives as Inhibitors of Matrix Metalloproteinase-2: Theoretical Calculations and Experimental Results | 1-gen-2010 | Lattanzi, Gianluca; Ilenia, Giangreco; Nicolotti, Orazio; Catto, Marco; Angelo, Carotti |